InspireMD (STU:II2) Accumulated Depreciation: €0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:II2 InspireMD Inc STU:II2
47 GF Score
Price €0.73
GF Value €1.43
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is InspireMD Accumulated Depreciation?

InspireMD STU:II2 -0.68% 47 Accumulated Depreciation is €0.00 Mil as of Jun. 2026. GuruFocus rates STU:II2 with a GF Score™ of 47/100 and a GF Value™ of €1.43 (Possible Value Trap). The stock has 3 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

InspireMD's quarterly accumulated depreciation declined from Dec. 2025 (€-2.33 Mil) to Mar. 2026 (€0.00 Mil) but then stayed the same from Mar. 2026 (€0.00 Mil) to Jun. 2026 (€0.00 Mil).

InspireMD's annual accumulated depreciation increased from Dec. 2023 (€-1.87 Mil) to Dec. 2024 (€-2.22 Mil) and increased from Dec. 2024 (€-2.22 Mil) to Dec. 2025 (€-2.33 Mil).

InspireMD Accumulated Depreciation Related Terms

InspireMD Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for InspireMD's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InspireMD Accumulated Depreciation Chart

InspireMD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.53 -1.80 -1.87 -2.22 -2.33

InspireMD Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -2.33 0.00 0.00
STU:II2
47GF Score
InspireMD Inc STU:II2
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InspireMD Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of €0.00 Mil mean?
InspireMD (STU:II2) has a Accumulated Depreciation of €0.00 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on InspireMD and its competitors.
Is InspireMD's Accumulated Depreciation too high?
InspireMD's current Accumulated Depreciation is €0.00 Mil. Overall, InspireMD has a GF Score™ of 47/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does InspireMD's Accumulated Depreciation compare to TELA and BDMD?
InspireMD's Accumulated Depreciation of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Medical Devices & Instruments company?
A good Accumulated Depreciation depends on the Medical Devices & Instruments industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on InspireMD and its competitors. InspireMD's current Accumulated Depreciation is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InspireMD stock overvalued right now?
Based on GuruFocus' analysis, InspireMD (STU:II2) is currently considered Possible Value Trap. The stock's GF Value™ is €1.43, compared to a current price of €0.73 — trading 49% below its estimated fair value. The current Accumulated Depreciation is €0.00 Mil. InspireMD's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For InspireMD (STU:II2), the current Accumulated Depreciation is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InspireMD (STU:II2) Overvalued in 2026?

Based on GuruFocus' analysis, InspireMD stock appears to be undervalued. The current stock price of €0.73 is trading 49% below its estimated GF Value™ of €1.43. GuruFocus considers InspireMD to be Possible Value Trap.

Key valuation signals for STU:II2:

  • Accumulated Depreciation: €0.00 Mil
  • GF Value™: €1.43 vs. price of €0.73 (49% below fair value)
  • GF Score™: 47/100 with 3 warning signs

No single metric tells the full story. See the STU:II2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InspireMD Business Description

Other Exchanges NSPR:USA
Address 6303 Waterford District Drive, Suite 215, Miami, FL, USA, 33126
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
47GF Score

Get the complete analysis for STU:II2

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.73
Price
€1.43
GF Value